Pemphigus foliaceus treated with etanercept

Journal of the American Academy of Dermatology

Volumn 55, Issue 6, 2006, Pages 1107-1108

  Gubinelli, Emanuela ^a   Bergamo, Fabio ^a   Didona, Biagio ^a   Annessi, Giorgio ^a   Atzori, Francesco ^a   Raskovic, Desanka ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; PEMPHIGUS FOLIACEUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT RESPONSE;

BIOLOGICAL RESPONSE MODIFIERS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PEMPHIGUS; RECEPTORS, TUMOR NECROSIS FACTOR; REMISSION INDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750833417     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.08.041     Document Type: Article

References (5)

1. Lopez-Robles E., Avalos-Diaz E., Vega-Memije E., Hojyo-Tomoka T., Villalobos R., Fraire S., et al. TNFalpha and IL-6 are mediators in the blistering process of pemphigus. Int J Dermatol 40 (2001) 185-188
2. Feliciani C., Toto P., Amerio P., Pour S.M., Coscione G., Shivji G., et al. In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis. J Invest Dermatol 114 (2000) 71-77
3. Lin M.H., Hsu C.K., and Lee J.Y. Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser. Arch Dermatol 141 (2005) 680-682
4. Berookhim B., Fischer H.D., and Weinberg J.M. Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist. Cutis 74 (2004) 245-247
5. Sacher C., Rubbert A., Konig C., Scharffetter-Kochanek K., Krieg T., and Hunzelmann N. Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept. J Am Acad Dermatol 46 (2002) 113-115